YCM
Yiheng Capital Management’s Akero Therapeutics AKRO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16M | Sell |
299,791
-60,000
| -17% | -$3.2M | 1.44% | 6 |
|
|
2025
Q1 | $14.6M | Sell |
359,791
-306,354
| -46% | -$12.4M | 1.35% | 7 |
|
|
2024
Q4 | $18.5M | Sell |
666,145
-92,624
| -12% | -$2.58M | 0.71% | 8 |
|
|
2024
Q3 | $21.8M | Sell |
758,769
-675,410
| -47% | -$19.4M | 1.12% | 8 |
|
|
2024
Q2 | $33.6M | Hold |
1,434,179
| – | – | 2.71% | 7 |
|
|
2024
Q1 | $36.2M | Sell |
1,434,179
-489,495
| -25% | -$12.4M | 2.01% | 8 |
|
|
2023
Q4 | $44.9M | Buy |
1,923,674
+702,000
| +57% | +$16.4M | 2.59% | 8 |
|
|
2023
Q3 | $61.8M | Buy |
1,221,674
+20,083
| +2% | +$1.02M | 3.15% | 7 |
|
|
2023
Q2 | $56.1M | Buy |
1,201,591
+75,800
| +7% | +$3.54M | 3.03% | 9 |
|
|
2023
Q1 | $43.1M | Sell |
1,125,791
-343,114
| -23% | -$13.1M | 1.7% | 12 |
|
|
2022
Q4 | $80.5M | Sell |
1,468,905
-630,241
| -30% | -$34.5M | 3.56% | 6 |
|
|
2022
Q3 | $71.5M | Buy |
2,099,146
+216,448
| +11% | +$7.37M | 4.41% | 6 |
|
|
2022
Q2 | $17.8M | Buy |
1,882,698
+329,708
| +21% | +$3.12M | 1.02% | 19 |
|
|
2022
Q1 | $22M | Buy |
1,552,990
+1,900
| +0.1% | +$27K | 1.01% | 19 |
|
|
2021
Q4 | $32.8M | Buy |
1,551,090
+29,900
| +2% | +$632K | 1.67% | 16 |
|
|
2021
Q3 | $34M | Buy |
1,521,190
+22,252
| +1% | +$497K | 1.67% | 18 |
|
|
2021
Q2 | $37.2M | Buy |
1,498,938
+1,230,656
| +459% | +$30.5M | 1.5% | 15 |
|
|
2021
Q1 | $7.78M | Buy |
+268,282
| New | +$7.78M | 0.35% | 20 |
|